Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 452,000 | 448,000 | 319,000 | 164,000 | 671,000 |
| Depreciation Amortization | 220,000 | 167,000 | 111,000 | 56,000 | 200,000 |
| Income taxes - deferred | 132,000 | 140,000 | 102,000 | 58,000 | 229,000 |
| Accounts receivable | -72,000 | -112,000 | -87,000 | -56,000 | -120,000 |
| Accounts payable and accrued liabilities | 30,000 | 80,000 | 100,000 | 72,000 | 4,000 |
| Other Working Capital | -123,000 | -210,000 | -121,000 | -95,000 | -350,000 |
| Other Operating Activity | -32,000 | -55,000 | -84,000 | -28,000 | -89,000 |
| Operating Cash Flow | $607,000 | $458,000 | $340,000 | $171,000 | $545,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -246,000 | -207,000 | -134,000 | -80,000 | -316,000 |
| Net Acquisitions | -34,000 | N/A | N/A | N/A | -622,000 |
| Purchase Of Investment | -499,000 | -1,569,000 | -1,159,000 | -603,000 | -2,983,000 |
| Sale Of Investment | 209,000 | 1,423,000 | 1,051,000 | 487,000 | 3,273,000 |
| Purchase Sale Intangibles | -146,000 | -94,000 | -92,000 | -38,000 | -72,000 |
| Other Investing Activity | -130,000 | -82,000 | -82,000 | -28,000 | -34,000 |
| Investing Cash Flow | $-700,000 | $-435,000 | $-324,000 | $-224,000 | $-682,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 215,000 | 130,000 | 30,000 | 1,000 | 287,000 |
| Common Stock Issued | 4,000 | 4,000 | 3,000 | 2,000 | 85,000 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -16,000 |
| Dividend Paid | -71,000 | -74,000 | -75,000 | N/A | -78,000 |
| Other Financing Activity | -60,000 | -45,000 | -33,000 | -17,000 | -56,000 |
| Financing Cash Flow | $88,000 | $15,000 | $-75,000 | $-14,000 | $222,000 |
| Exchange Rate Effect | 13,000 | 8,000 | 4,000 | 2,000 | 1,000 |
| Beginning Cash Position | 156,000 | 162,000 | 164,000 | 170,000 | 85,000 |
| End Cash Position | 164,000 | 208,000 | 112,000 | 105,000 | 171,000 |
| Net Cash Flow | $8,000 | $46,000 | $-52,000 | $-65,000 | $86,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 607,000 | 458,000 | 340,000 | 171,000 | 545,000 |
| Capital Expenditure | -249,000 | -209,000 | -136,000 | -80,000 | -322,000 |
| Free Cash Flow | 358,000 | 249,000 | 204,000 | 91,000 | 223,000 |